Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Alexander V., Karaulov"'
Autor:
Alexander D. Dushkin, Maxim S. Afanasiev, Stanislav S. Afanasiev, Tatyana G. Grishacheva, Alexander V. Karaulov
Publikováno v:
Digital Diagnostics, Vol 5, Iss 1S, Pp 18-20 (2024)
BACKGROUND: Visual inspection and colposcopy are subjective methods of cervical evaluation. Currently, the majority of colposcopes are equipped with the capacity to digitally transmit and record cervical images, in addition to modern software for ima
Externí odkaz:
https://doaj.org/article/9074f54f06b44e8fbbd70cbbe5bb800d
Autor:
Daria S. Fomina, Sergey V. Fedosenko, Elena N. Bobrikova, Anton A. Chernov, Olga A. Mukhina, Marina S. Lebedkina, Alexander V. Karaulov, Asel Yu. Nurtazina, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 95, Iss 7, Pp 568-573 (2023)
Background. Dupilumab, a fully human monoclonal antibody directed against the common -subunit of interleukin (IL)-4 receptors and blocking signaling from both IL-4 and IL-13, may be recommended for the treatment of moderate to severe atopic dermatiti
Externí odkaz:
https://doaj.org/article/65e68e2d00ba4c998efe7da08dfc2317
Autor:
Daria S. Fomina, Olga A. Mukhina, Valeria I. Mikhailova, Marina S. Lebedkina, Elizaveta L. Sedova, Elena N. Bobrikova, Olga G. Elisyutina, Elena S. Fedenko, Tair T. Nurpeisov, Alexander V. Karaulov, Mar’yana A. Lysenko, Luis Felipe C. Ensina
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionThe role of upadacitinib in the management of moderate to severe atopic dermatitis seems promising, but more data on its efficacy and safety are needed. This study endeavors to assess the practical impact and safety of upadacitinib in pat
Externí odkaz:
https://doaj.org/article/8a93099ff0bf454dbc4f521616c8cb52
Autor:
Anna A. Roppelt, Marina S. Lebedkina, Anton A. Chernov, Tatiana S. Kruglova, Olga A. Mukhina, Yulia D. Yukhnovskaya, Farida A. Samedova, Ulyana A. Mаrkina, Gerelma V. Andrenova, Alexander V. Karaulov, Mariana A. Lysenko, Daria S. Fomina
Publikováno v:
Терапевтический архив, Vol 95, Iss 1, Pp 78-84 (2023)
Background. Primary immunodeficiencies (PIDs), now known as inborn errors of immunity, are a group of inherited diseases caused by defects in the genes that control the immune response. Patients with PIDs have risks of developing a severe course and/
Externí odkaz:
https://doaj.org/article/2d43eed5d4bf4eb69941f07a641d44c2
Autor:
Daria S. Fomina, Marina S. Lebedkina, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Sergey S. Andreev, Anton A. Chernov, Inna V. Dolzhikova, Tatyana S. Kruglova, Gerelma V. Andrenova, Amir I. Tukhvatulin, Dmitry V. Shcheblyakov, Alexander V. Karaulov, Maryana A. Lysenko, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Several virus-neutralizing monoclonal antibodies (mAbs) have become new tools in the treatment of the coronavirus disease (COVID-19), but their effectiveness against the rapidly mutating virus is questionable. The present study investigated the effec
Externí odkaz:
https://doaj.org/article/670820e7fe5d4672ba2d2ca795a32834
Autor:
Ekaterina A. Nikitina, Daria S. Fomina, Ulyana A. Markina, Sergey S. Andreev, Yuri V. Streltsov, Tatiana S. Kruglova, Marina S. Lebedkina, Alexander V. Karaulov, Maryana A. Lysenko
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, potentially life-threatening syndromes characterized by the development of necrotic epidermal and mucosal lesions. The most common etiologic cause of SJS/TEN is drug-induce
Externí odkaz:
https://doaj.org/article/a2672194f8cd4f73843ec3187797f6e0
Autor:
Ulyana A. Markina, Daria S. Fomina, Marina S. Lebedkina, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva, Zinaida Yu. Mutovina, Alexander V. Karaulov, Ekaterina I. Alexeeva, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 675-682 (2022)
Background. The use of virus-neutralizing monoclonal antibodies is an effective method of etiotropic therapy for SARS-CoV-2 in patients of high-risk groups of severe COVID-19. Regdanvimab is a single-component monoclonal antibodies immunoglobulin G1,
Externí odkaz:
https://doaj.org/article/1ca7266523cb42cb8962e01de2e8c208
Autor:
Maxim Afanasiev, Alexander Dushkin, Tatyana Grishacheva, Stanislav Afanasiev, Yuri Nesvizhsky, Alexander V. Karaulov, Andrey Pylev
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 506-519 (2021)
Cervical cancer is an important problem in women’s health and a worldwide oncological disease. In 2018, the WHO registered 569,847 new cases in the world, and 3.4% were in the Russian Federation. We describe here a case of invasive cervical cancer
Externí odkaz:
https://doaj.org/article/9130ba2714a1485ab69e08cc70e7dd57
Publikováno v:
Терапевтический архив, Vol 93, Iss 1, Pp 108-113 (2021)
During a pandemic, nonspecific immunoprophylaxis of SARS-CoV-2 infection and other acute respiratory infections (ARI), which can worsen the course of COVID-19, is increasingly in demand in addition to specific immunization. BCG vaccine appears to be
Externí odkaz:
https://doaj.org/article/95fad924b7e24a6a9f3e5655e1fc8a46
Autor:
Daria Fomina, Mar’yana A. Lysenko, Irina P. Beloglazova, Zinaida Yu. Mutovina, Nataliya G. Poteshkina, Inna V. Samsonova, Tat’yana S. Kruglova, Anton A. Chernov, Alexander V. Karaulov
Publikováno v:
Pathogens and Immunity, Vol 5, Iss 1, Pp 327-341 (2020)
Background: Pandemic COVID-19 pneumonia due to SARS-2 is an important cause of morbidity and mortality. Emerging evidence links poor outcomes to an inflammatory cytokine storm. Methods: We treated 89 hospitalized patients with COVID-19 pneumonia and
Externí odkaz:
https://doaj.org/article/693405732e0746a78a68eff75b427535